-
Integrated Protocols for mRNA Lipid Nanoparticle Evaluation
2026-05-30
Ma et al. present a comprehensive protocol for formulating, characterizing, and evaluating mRNA lipid nanoparticles (LNPs), aiming to lower technical barriers in the field. Their stepwise workflow supports reproducible mRNA LNP production and assessment, facilitating translational research in diverse applications.
-
Phosphotungstic Acid Negative Stain Solution for Virus Imagi
2026-05-29
Harness the power of 2% Phosphotungstic Acid Negative Stain Solution for high-contrast visualization of viruses, macromolecules, and microbial structures in electron microscopy. This guide demystifies workflow optimization, troubleshooting, and the translation of novel lectin-based viral imaging insights into practical lab protocols.
-
JC-1 Mitochondrial Membrane Potential Assay Kit: Advanced Wo
2026-05-29
Unlock robust, ratiometric mitochondrial membrane potential analysis with the JC-1 Mitochondrial Membrane Potential Assay Kit. This guide delivers expert workflow enhancements, troubleshooting, and translational insights for apoptosis and immunomodulation research.
-
28S rRNA Expansion Segments Shape Multilayered Nucleolar Arc
2026-05-28
Wei et al. reveal that expansion segments in 28S rRNA are key determinants of the multilayered architecture of the nucleolus, functioning as modular elements that drive complex RNA-RNA interactions. Their mechanistic dissection provides new insight into the evolution of nucleolar structure and offers a framework for reconstituting layered nucleolar assemblies in vitro.
-
tFUS Modulates Nespas/miR-383-3p/SHP2 Axis in Post-Stroke Ne
2026-05-28
This study demonstrates that transcranial focused ultrasound stimulation (tFUS) alleviates NLRP3-driven neuroinflammation after ischemic stroke by upregulating the Nespas/miR-383-3p/SHP2 pathway. The findings highlight SHP2 as a critical mediator of microglial inflammatory responses and suggest new molecular targets for post-stroke therapy.
-
Prestained Protein Marker (Triple color, EDTA free, 10-250 k
2026-05-27
The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) addresses rapid, visual protein sizing and transfer monitoring in SDS-PAGE and Western blot workflows while maintaining compatibility with EDTA-sensitive protocols. This product should not be used for post-electrophoresis protein recovery or absolute protein quantification.
-
Ethacridine Lactate Monohydrate: Precision Antiseptic Use in
2026-05-27
Ethacridine lactate monohydrate (7-ethoxyacridine-3,9-diamine) delivers high-purity, rapid-action antiseptic control for advanced cell and chromatin assays. Its solubility profile and validated mechanism enable reproducible workflows where microbial inhibition is non-negotiable. Integrated troubleshooting and workflow guidance make it the gold standard for contamination-free, epigenetic and differentiation studies.
-
ATRA Overcomes PARP Inhibitor Resistance in Ovarian Cancer
2026-05-26
This study demonstrates that all-trans retinoic acid (ATRA) sensitizes epithelial ovarian cancer (EOC) cells to PARP inhibitors following cisplatin exposure by downregulating a resistance-associated molecular signature and reducing intracellular NAD+ levels. The findings reveal a promising new maintenance strategy for improving outcomes in platinum-resistant EOC and suggest that modulating NAD metabolism is a viable research direction.
-
SERCA2 Dysfunction Drives Pulmonary Vascular Remodeling via
2026-05-26
This study reveals that dysfunction of SERCA2 promotes inflammation and pulmonary vascular remodeling by downregulating the PPARγ/PGC1α/Nrf2 axis in pulmonary artery smooth muscle cells. These findings elucidate a mechanistic link between calcium homeostasis, oxidative stress, and vascular pathology, offering new targets for pulmonary hypertension intervention.
-
Cy5-UTP: Illuminating RNA Phase Separation and Mitotic Contr
2026-05-25
This thought-leadership article explores how Cy5-UTP (Cyanine 5-UTP) empowers translational researchers to dissect RNA-driven phase separation and mitotic regulation. Drawing on recent mechanistic insights and validated workflows, we map the strategic value of advanced RNA labeling in probing the interplay of U3 snoRNA and DDX21 in the perichromosomal region, highlighting both experimental and translational impact.
-
KPT330 Enhances CRISPR-Cas9 Specificity via mRNA Nuclear Exp
2026-05-25
The referenced study identifies KPT330, an FDA-approved SINE compound, as a novel indirect modulator of CRISPR-Cas9 and base editing precision through selective inhibition of Cas9 mRNA nuclear export. This approach offers a new layer of temporal control to improve genome-editing specificity, with implications for safer and more precise gene editing in mammalian cells.
-
Comparative Analysis of Radiosensitizers in 2D vs 3D Cancer
2026-05-24
This study systematically compares the radiosensitizing effects of molecular inhibitors—targeting DNA repair and apoptotic pathways—across 2D and 3D lung cancer cell cultures. Findings highlight the importance of physiologically relevant models for prioritizing candidates like ATR inhibitors and guide preclinical assay design for cancer radiotherapy research.
-
HyperScript RT SuperMix for qPCR: Precision in Complex RNA A
2026-05-23
HyperScript™ RT SuperMix for qPCR enables robust cDNA synthesis even from low-abundance, structurally complex RNA, reducing workflow steps and maximizing reproducibility for gene expression analysis. This article demystifies protocol choices, troubleshooting, and practical insights for translational cancer research and beyond.
-
Promethazine HCl in Immunometabolism: Beyond Histamine Antag
2026-05-22
Explore how Promethazine HCl, a phenothiazine derivative, is redefining inflammation and immunometabolism research by modulating macrophage function and host defense. This cornerstone article delivers a unique, mechanism-focused analysis for advanced scientific workflows.
-
Biomimetic Chromatography for Predicting Pulmonary Drug Perm
2026-05-22
This study provides a rigorous comparison of biomimetic chromatographic techniques—IAM-LC-MS and OT-CEC-MS—for modeling lung permeability of pharmaceuticals. By validating these high-throughput, mass spectrometry-compatible methods on a diverse set of compounds, the research advances early-stage pharmacokinetic profiling and drug development strategies.